Earnings Date
EPS
Quarterly Revenue
Annual Revenue (as of Sep 30)
Earnings Recap
Monte Rosa Therapeutics (NASDAQ:GLUE) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Monte Rosa Therapeutics beat estimated earnings by 2.78%, reporting an EPS of $-0.7 versus an estimate of $-0.72.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 0.15% increase in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Earnings History
Analyze the earnings history of Monte Rosa Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/09/2023 | AM | GLUE | Q3 | -$0.58 | -$0.72 | -$0.70 | 2.78% | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2023 | AM | GLUE | Q2 | -$0.57 | -$0.70 | -$0.71 | -1.43% | $0.00 | — | $0.00 | — | Get Alert |
| 05/11/2023 | AM | GLUE | Q1 | -$0.51 | -$0.68 | -$0.65 | 4.41% | $0.00 | — | $0.00 | — | Get Alert |
| 03/16/2023 | AM | GLUE | Q4 | -$0.11 | — | -$0.63 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/10/2022 | AM | GLUE | Q3 | -$0.43 | — | -$0.58 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/11/2022 | AM | GLUE | Q2 | -$3.63 | — | -$0.57 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/11/2022 | AM | GLUE | Q1 | -$7.18 | — | -$0.51 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/29/2022 | AM | GLUE | Q4 | — | — | -$0.11 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/10/2021 | AM | GLUE | Q3 | -$4.29 | — | -$0.43 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/12/2021 | AM | GLUE | Q2 | -$3.64 | — | -$3.63 | — | $0.00 | — | $0.00 | — | Get Alert |
When is Monte Rosa Therapeutics (NASDAQ:GLUE) reporting earnings?
Monte Rosa Therapeutics (GLUE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3.
What were the latest earnings per share (EPS) for Monte Rosa Therapeutics (NASDAQ:GLUE)?
Monte Rosa Therapeutics (GLUE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3 and the Actual EPS was $-0.70, which beat the estimate of $-0.72.
What were Monte Rosa Therapeutics’s (NASDAQ:GLUE) revenues?
Monte Rosa Therapeutics (GLUE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.